CTI BioPharma Story

<div class='circular--portrait' style='background:#FF01C9;color: #FFF8DC;font-size:4em;'>CB</div>
CTIC -- USA Stock  

USD 3.26  0.03  0.91%

CTI BioPharma Stock News module provides quick insight into current market opportunities from investing in CTI BioPharma Corp. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use CTI BioPharma Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Continue to CTI BioPharma Hype Analysis, CTI BioPharma Correlation and CTI BioPharma Performance.

Search Today's Stock News

 
Refresh
CTI BioPharma stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of CTI BioPharma daily returns and investor perception about the current pice of CTI BioPharma Corp as well as its diversification or hedging effects on your existing portfolios.
Acquisition by Bruce Seeley of 500 shares of CTI BioPharma subject to Rule 16b-3
Filed transaction by Cti Biopharma Corp officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

CTI BioPharma insider trading alert for grant of common stock by Bruce Seeley, EVP Chief Operating Officer, on 2nd of July 2020. This event was filed by Cti Biopharma Corp with SEC on 2020-07-02. Statement of changes in beneficial ownership - SEC Form 4. Bruce Seeley currently serves as executive vice president and chief commercial officer of CTI BioPharma Corp

Cash Floor Correlation

Click cells to compare fundamentals   

Price to Earning

Price to Earning Comparative Analysis

CTI BioPharma is currently under evaluation in price to earning category among related companies. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Peers

CTI BioPharma Related Equities

DMACDiaMedica Therapeutics   11.57   
0%
61.0%
DNLIDenali Therapeutics   9.66   
0%
51.0%
EDITEditas Medicine   3.79   
0%
20.0%
NKNantKwest   2.61   
0%
13.0%
DYAIDYADIC INTERNATIONAL INC   1.35   
0%
7.0%
DVAXDynavax Technologies Corporation   0.19   
1.0%
0%
EQEquillium   0.61   
3.0%
0%
DRNADicerna Pharmaceuticals   1.58   
8.0%
0%
EARSAuris Medical Holding   3.23   
17.0%
0%
DTILPrecision BioSciences   18.77   
100.0%
0%
Continue to CTI BioPharma Hype Analysis, CTI BioPharma Correlation and CTI BioPharma Performance. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.